Glycolytic Inhibitors Potentiated the Activity of Paclitaxel and Their Nanoencapsulation Increased Their Delivery in a Lung Cancer Model
admin-cespu
Bibliographic reference:
Cunha, A.; Rocha, A.C.; Barbosa, F.; Baião, A.; Silva, P.; Sarmento, B.; Queirós, O. Glycolytic Inhibitors Potentiated the Activity of Paclitaxel and Their Nanoencapsulation Increased Their Delivery in a Lung Cancer Model. Pharmaceutics 2022, 14, 2021. https://doi.org/10.3390/pharmaceutics14102021
Cunha, A.; Rocha, A.C.; Barbosa, F.; Baião, A.; Silva, P.; Sarmento, B.; Queirós, O. Glycolytic Inhibitors Potentiated the Activity of Paclitaxel and Their Nanoencapsulation Increased Their Delivery in a Lung Cancer Model. Pharmaceutics 2022, 14, 2021. https://doi.org/10.3390/pharmaceutics14102021